News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
269,364 Results
Type
Article (14295)
Company Profile (281)
Press Release (254788)
Multimedia
Podcasts (49)
Webinars (7)
Section
Business (79561)
Career Advice (153)
Deals (13238)
Drug Delivery (35)
Drug Development (50474)
Employer Resources (31)
FDA (5731)
Job Trends (5141)
News (144497)
Policy (10041)
Tag
Academia (917)
Accelerated approval (3)
Adcomms (13)
Allergies (52)
Alliances (21695)
ALS (69)
Alzheimer's disease (854)
Antibody-drug conjugate (ADC) (110)
Approvals (5758)
Artificial intelligence (134)
Autoimmune disease (19)
Automation (5)
Bankruptcy (105)
Best Places to Work (4559)
BIOSECURE Act (6)
Biosimilars (44)
Biotechnology (232)
Bladder cancer (61)
Brain cancer (20)
Breast cancer (165)
Cancer (1546)
Cardiovascular disease (122)
Career advice (134)
Career pathing (2)
CAR-T (127)
Cell therapy (349)
Cervical cancer (9)
Clinical research (41210)
Collaboration (568)
Compensation (285)
Complete response letters (13)
COVID-19 (1036)
CRISPR (47)
C-suite (173)
Cystic fibrosis (78)
Data (1652)
Denatured (11)
Depression (32)
Diabetes (146)
Diagnostics (1304)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (88)
Drug pricing (29)
Drug shortages (3)
Duchenne muscular dystrophy (95)
Earnings (30288)
Editorial (19)
Employer branding (4)
Employer resources (29)
Events (48876)
Executive appointments (479)
FDA (6518)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (525)
Gene editing (105)
Generative AI (10)
Gene therapy (273)
GLP-1 (375)
Government (1084)
Grass and pollen (2)
Guidances (75)
Healthcare (6598)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (100)
Indications (20)
Infectious disease (1103)
Inflammatory bowel disease (119)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (68)
Interviews (18)
IPO (7282)
IRA (11)
Job creations (864)
Job search strategy (127)
Kidney cancer (7)
Labor market (8)
Layoffs (215)
Leadership (3)
Legal (1388)
Liver cancer (34)
Lung cancer (212)
Lymphoma (107)
Machine learning (5)
Management (7)
Manufacturing (148)
MASH (65)
Medical device (2606)
Medtech (2607)
Mergers & acquisitions (6299)
Metabolic disorders (416)
Multiple sclerosis (55)
NASH (13)
Neurodegenerative disease (78)
Neuropsychiatric disorders (26)
Neuroscience (1292)
NextGen: Class of 2025 (2018)
Non-profit (853)
Now hiring (23)
Obesity (201)
Opinion (103)
Ovarian cancer (67)
Pain (45)
Pancreatic cancer (60)
Parkinson's disease (126)
Partnered (8)
Patents (141)
Patient recruitment (85)
Peanut (35)
People (25700)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14565)
Phase II (19176)
Phase III (12104)
Pipeline (1006)
Policy (49)
Postmarket research (852)
Preclinical (6172)
Press Release (30)
Prostate cancer (64)
Psychedelics (35)
Radiopharmaceuticals (215)
Rare diseases (302)
Real estate (1420)
Recruiting (12)
Regulatory (8690)
Reports (18)
Research institute (939)
Resumes & cover letters (17)
Rett syndrome (5)
RNA editing (7)
RSV (10)
Schizophrenia (64)
Series A (103)
Series B (71)
Service/supplier (1)
Sickle cell disease (43)
Special edition (12)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1977)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (12)
The Weekly (37)
Vaccines (219)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (131)
Last 7 days (619)
Last 30 days (2110)
Last 365 days (19377)
2025 (7476)
2024 (20552)
2023 (22414)
2022 (26827)
2021 (27805)
2020 (23360)
2019 (16225)
2018 (11740)
2017 (13745)
2016 (11840)
2015 (14354)
2014 (10397)
2013 (7486)
2012 (7536)
2011 (7621)
2010 (7432)
Location
Africa (149)
Alabama (44)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17367)
Australia (2950)
California (4189)
Canada (1197)
China (379)
Colorado (160)
Connecticut (157)
Delaware (112)
Europe (37398)
Florida (510)
Georgia (128)
Idaho (16)
Illinois (245)
India (11)
Indiana (94)
Iowa (3)
Japan (83)
Kansas (64)
Kentucky (5)
Louisiana (4)
Maine (11)
Maryland (502)
Massachusetts (3324)
Michigan (77)
Minnesota (156)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (1024)
New Mexico (12)
New York (1112)
North Carolina (579)
North Dakota (6)
Northern California (1872)
Ohio (118)
Oklahoma (9)
Oregon (21)
Pennsylvania (783)
Puerto Rico (6)
Rhode Island (19)
South America (208)
South Carolina (5)
Southern California (1601)
Tennessee (26)
Texas (484)
United States (14237)
Utah (56)
Virginia (87)
Washington D.C. (32)
Washington State (370)
Wisconsin (19)
269,364 Results for "ovid therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results
May 13, 2025
·
11 min read
Press Releases
Ovid Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
April 2, 2025
·
1 min read
Press Releases
Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors
March 3, 2025
·
4 min read
Press Releases
Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results
March 11, 2025
·
17 min read
Press Releases
Ovid Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
February 27, 2025
·
1 min read
Press Releases
Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 5, 2025
·
1 min read
Press Releases
Wolters Kluwer Empowers Medical Research in India with Ovid as part of One Nation One Subscription (ONOS)
April 24, 2025
·
2 min read
Press Releases
Ovid Therapeutics to Host Investor Event
October 31, 2024
·
4 min read
Business
Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
Ovid Therapeutics Inc., a biopharmaceutical company dedicated to meaningfully improving the lives of people affected by rare epilepsies and brain conditions, reported business updates and financial results for the first quarter ended March 31, 2024.
May 14, 2024
·
11 min read
Drug Development
Ovid Therapeutics Reports on Takeda’s Announcement of Phase 3 Topline Study Results for Soticlestat
Ovid Therapeutics Inc., a biopharmaceutical company dedicated to meaningfully improving the lives of people affected by rare epilepsies and brain conditions, reports that Takeda Pharmaceutical Company Limited has announced topline data from its Phase 3 SKYLINE and SKYWAY studies evaluating soticlestat for the treatment of Dravet syndrome and Lennox-Gastaut syndrome.
June 17, 2024
·
12 min read
1 of 26,937
Next
